Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CG Oncology (CGON) Total Liabilities: 2023-2025

Historic Total Liabilities for CG Oncology (CGON) over the last 2 years, with Sep 2025 value amounting to $42.3 million.

  • CG Oncology's Total Liabilities rose 169.22% to $42.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $42.3 million, marking a year-over-year increase of 169.22%. This contributed to the annual value of $21.4 million for FY2024, which is 47.61% up from last year.
  • As of Q3 2025, CG Oncology's Total Liabilities stood at $42.3 million, which was up 35.97% from $31.1 million recorded in Q2 2025.
  • In the past 5 years, CG Oncology's Total Liabilities registered a high of $42.3 million during Q3 2025, and its lowest value of $10.2 million during Q1 2024.
  • Moreover, its 3-year median value for Total Liabilities was $18.6 million (2024), whereas its average is $21.3 million.
  • Data for CG Oncology's Total Liabilities shows a peak YoY skyrocketed of 169.22% (in 2025) over the last 5 years.
  • Quarterly analysis of 3 years shows CG Oncology's Total Liabilities stood at $14.5 million in 2023, then skyrocketed by 47.61% to $21.4 million in 2024, then soared by 169.22% to $42.3 million in 2025.
  • Its last three reported values are $42.3 million in Q3 2025, $31.1 million for Q2 2025, and $23.4 million during Q1 2025.